Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 8, 2014, Pages 853-860

  Zhang, Feng ^a   Zhuge, Yuzheng ^a   Zou, Xiaoping ^a   Zhang, Ming ^a   Peng, Chunyan ^a   Li, Zhenlei ^a   Wang, Tingting ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

liver cirrhosis; prognosis; scoring; transjugular intrahepatic portosystemic shunt

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BARE METAL STENT; BILIRUBIN BLOOD LEVEL; BONN TIPS EARLY MORTALITY SCORE; CHILD TURCOTTE PUGH SCORE; CHINESE; COHORT ANALYSIS; EMORY SCORE; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; SURVIVAL RATE; THROMBOCYTE COUNT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; ADVERSE EFFECTS; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; BILIRUBIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET COUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84904068169     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000134     Document Type: Article

References (30)

1. Garcia-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362:2370-2379.
2. Luca A, DAmico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212:411-421.
3. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. J Vasc Interv Radiol 2005; 16:449-455.
4. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
5. Pan JJ, Chen C, Caridi JG, Geller B, Firpi R, Machicao VI, et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years experience from a single tertiary medical center. J Vasc Interv Radiol 2008; 19:1576-1581.
6. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
7. Montgomery A, Ferral H, Vasan R, Postoak DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 2005; 28:307-312.
8. Ripoll C, Lastra P, Rincón D, Catalina V, Bañares R. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis. Scand J Gastroenterol 2012; 47:204-211.
9. Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci 2011; 56:977-987.
10. Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, et al. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2013; 24:411-420.
11. Tzeng WS, Wu RH, Lin CY, Chen JJ, Sheu MJ, Koay LB, Lee C. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol 2009; 10:481-489.
12. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98:1167-1174.
13. Orloff MJ, Vaida F, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, et al. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Res 2012; 178:139-146.
14. Bureau C, Métivier S, DAmico M, Péron JM, Otal P, Pagan JC, et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 2011; 54:901-907.
15. Tsien C, Shah SN, McCullough AJ, Dasarathy S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol 2013; 25:85-93.
16. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009; 104:2458-2466.
17. Ghoshal UC, Das A. Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review. Hepatol Int 2008; 2:31-38.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
19. Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 2002; 14:723-731.
20. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, Boyer TD. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.
21. Rossle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
22. Blei AT, Córdoba J. Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol 2001; 96:1968-1976.
23. Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, McMahan CA. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231:231-236.
24. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006; 12:966-971.
25. Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, et al. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol 2012; 18:5211-5218.
26. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36:494-500.
27. Saugel B, Phillip V, Gaa J, Berger H, Lersch C, Schultheiss C, et al. Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: implications for selection of patients - a prospective study. Radiology 2012; 262:343-352.
28. Kumar A, Sharma P, Sarin SK. Adding variceal status to Child-Turcotte-Pugh score improves its performance in predicting early mortality in cirrhosis: the Child-Turcotte-Pugh-Kumar score. Eur J Gastroenterol Hepatol 2012; 24:1348-1349.
29. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007; 13:523-529.
30. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10:995-1000.